Relevance of the 21-gene expression assay in male breast cancer: A systematic review and meta-analysis

The Breast(2022)

引用 3|浏览0
暂无评分
摘要
•Overall, Recurrence Scores (RS) were similar in male and female patients.•RS testing in male breast cancer (MBC) favoured RS > 30 (P < 0.001).•Female patients were more likely to have RS < 18 (P < 0.001).•At meta-analysis, there was no difference in RS among female and MBC patients.•In the absence of matching, cautious interpretation of RS in MBC is required.
更多
查看译文
关键词
Male breast cancer,Cancer genomics,Precision oncology,Personalised medicine
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要